The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis Revisited

Psychosomatics

Volumn 53, Issue 2, 2012, Pages 103-115

  Dubovsky, Amelia N ^a   Arvikar, Sheila ^a   Stern, Theodore A ^a   Axelrod, Lloyd ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CLARITHROMYCIN; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; DEXAMETHASONE; ESTROGEN; ETIRACETAM; FLUOXETINE; GLUCOCORTICOID; HYDROCORTISONE; KETOCONAZOLE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; MEMANTINE; METHYLPREDNISOLONE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PHENYTOIN; PREDNISOLONE; PREDNISONE; SERTRALINE; STEROID; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; TRANQUILIZER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADRENAL SUPPRESSION; AGITATION; ALLERGY; ANXIETY DISORDER; ASTHMA; ATHEROSCLEROSIS; AUDITORY HALLUCINATION; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CATARACT; CATATONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; DELIRIUM; DEMENTIA; DEPERSONALIZATION; DEPRESSION; DIABETES MELLITUS; DISEASE COURSE; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG INHIBITION; DRUG MEGADOSE; DRUG SYNTHESIS; DRUG USE; ELECTROCONVULSIVE THERAPY; ENDOCRINE DISEASE; EUPHORIA; HALLUCINATION; HIGH RISK PATIENT; HIP OSTEOARTHRITIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATORY DISEASE; INSOMNIA; IRRITABILITY; LOW DRUG DOSE; LUNG DISEASE; LYMPHOCYTOPENIA; MANIA; MEDICAL LITERATURE; MENTAL DISEASE; MENTAL INSTABILITY; MENTAL PERFORMANCE; MOOD DISORDER; MORBIDITY; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYOPATHY; NEOPLASM; NEUROPSYCHIATRY; OBSESSION; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PARANOIA; PEPTIC ULCER; PREVALENCE; PSYCHOSIS; PURPURA; RESTLESSNESS; RETROBULBAR OPTIC NEUROPATHY; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; RUMINATION; SEX DIFFERENCE; SIDE EFFECT; SKIN ATROPHY; SKIN DISEASE; SYSTEMATIC REVIEW; VISUAL HALLUCINATION; AGE; BRAIN; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; EMOTIONAL DISORDER; HOSPITALIZATION; MEDLINE; PSYCHOLOGICAL ASPECT; SEX RATIO; WITHDRAWAL SYNDROME;

AFFECTIVE SYMPTOMS; AGE FACTORS; BRAIN; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; PSYCHOSES, SUBSTANCE-INDUCED; PUBMED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SUBSTANCE WITHDRAWAL SYNDROME; TRANQUILIZING AGENTS;

EID: 84863819625     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2011.12.007     Document Type: Review

References (90)

1. Donihi A.C., Raval D., Saul M., Korytkowski M.T., DeVita M.A. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006, 12(4). 358-262.
2. Fardet L., Petersen I., Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years. Rheumatology 2011, 50(11):1982-1990.
3. Choi H.K., Seeger J.D. Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey. Arthritis 2005, 53:528-535.
4. Halper J.P. Corticosteroids and behavioral disturbances. Principles of Corticosteroids Therapy 2002, 174-201. Arnold, London. A.N.. Lin, S.E. P (Eds.).
5. Warrington T.P., Botswick M.J. Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceedings 2006, 81(10):1361-1367.
6. Boland E.W., Headley N.E. Management of rheumatoid arthritis with smaller (maintenance) doses of cortisone acetate. JAMA 1950, 144:365.
7. Clark L.D., Bauer W., Cobb S. Preliminary observations on mental disturbances occuring in patients under therapy with cortisone and ACTH. N Engl J Med 1952, 246:205-216.
8. Rome H.P., Braceland F.J. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 1952, 108:641-651.
9. Hall R.C.W., Popkin M.K., Stickney S.K., Gardner E.R. Presentation of the steroid psychoses. J Nerv Ment Dis 1979, 167:229-236.
10. Kershner P., Cheng R.W. Psychiatric side effects of steroid therapy. Psychosomatics 1989, 30:135-139.
11. Lewis D.A., Smith R.E. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 1983, 5:319-332.
12. Ling M.H.M., Perry P.J., Tsuang M.T. Side effects of corticosteroid therapy. Arch Gen Psychiatry 1981, 18:471-477.
13. Wada K., Yamada N., Sato T., Suzuki H., Miki M., Lee Y., et al. Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001, 42:461-466.
14. Sirois F. Steroid psychosis: a review. Gen Hosp Psychiatry 2003, 25:27-33.
15. Bolanos S., Khan D., Hanczyc M., Bauer M., Dhanani N., Brown E. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol 2004, 92:500-505.
16. Goodwin F.K., Jamison K.R. Manic-Depressive Illness 1990, Oxford University Press, New York.
17. Wolkowitz O.M., Rubinow D., Doran A.R., Breier A., Berrettini W.H., Kling M.A., et al. Prednisone effects on neurochemistry and behaviour. Arch Gen Psychiatry 1990, 47:963-968.
18. Keenan P.A., Jacobson M.W., Soleymani R.M., Mayes M.D., Stress M.E., Yaldoo D.T. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 1996, 47:1396-1402.
19. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992, 32:756-765.
20. Wolkowitz O.M., Reus V.I., Canick J., Levin B., Lupien S.J. Glucocorticoid medication, memory, and steroid psychosis in medical illness. Ann NY Acad Sci 1997, 823:81-96.
21. Varney N.R., Alexander B., Macindoe J.H. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 1984, 141:369-372.
22. Keenan P.A., Jacobson M.W., Soleymani R.M., Newcomer J.W. Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann NY Acad Sci 1995, 761:400-402.
23. Brown E.S., Woolston D.J., Frol A., Bobadilla L., Khan D.A., Hanczyc M., et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 2004, 55:538-545.
24. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972, 13(5):694-698. Boston Collaborative Drug Surveillance Program.
25. Hong S.I., Cho D.H., Kang H.C., Chung D.J., Chung M.Y. Acute onset of steroid psychosis with very low dose of prednisolone in Sheehan's syndrome. Endocr J 2006, 53(2):25525-25528.
26. Sergent J.S., Lockshin M.D., Klempner M.S., Lipsky B.A. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med 1975, 58(5):644-654.
27. Rosenberg F.R., Sanders S., Nelson C.T. Pemphigus-a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976, 148:962-970.
28. Kenna H., Poon A., de los Angeles P., Koran L. Psychiatric complications of treatment with corticosteroids: Review with case report. Psychiatry Clin Neurosci 2011, 65:549-560.
29. Tiemensma J., Biermasz N.R., Middelkoop H.A., van der Mast R.C., Romijn J.A., Pereira A.M. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010, 95:E129-E141.
30. Stuart F.A., Segal T.Y., Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 2005, 90(5):500-506.
31. Okishiro N., Tanimukai H., Tsuneto S., Ito N. Can";steroid switching" improve steroid-induced psychosis in a patient with advanced cancer?. J Palliat Med 2009, 12:487-490.
32. Robinson D.E., Harrison-Hansley E., Spencer R.F. Steroid psychosis after an intra-articular injection. Ann Rheum Dis 2000, 59:927.
33. Samala R., Ciocon J.O. Steroid-induced hallucination following intra-articular administration: A case report and brief review. J Am Med Dir Assoc 2011, 12:609-610.
34. Benyamin R.M., Vallejo R., Kramer J., Rafeyan R. Corticosteroid induced psychosis in the pain management setting. Pain Physician 2008, 11:917-920.
35. Goldstein E.T., Preskorn S.H. Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder. Am J Psychiatry 1989, 146(8):1076-1077.
36. Sonino N., Fava G.A., Raffi A.R., Boscaro M., Fallo F. Clinical correlates of major depression in Cushing's disease. Psychopathology 1998, 31(6):302-306.
37. Naber D., Sand P., Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 1996, 21(1):25-31.
38. Brown E.S., Suppes T., Khan D.A., Carmody T.J. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 2002, 22(1):55-61.
39. Sharfstein S.S., Sack D.S., Fauci A.S. Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. JAMA 1982, 248(22):2987-2989.
40. Glynne-Jones R., Vernon C.C., Bell G. Is steroid psychosis preventable by divided doses?. Lancet 1986, 2(8520):1404.
41. Horstmann S., Binder E. Glucocorticoids as predictors of treatment response in depression. Harv Rev Psychiatry 2011, 19:125-143.
42. Pokladinkova J., Meyboom R.H.B., Vlcek J., Edwards R.I. Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the International Pharmacovigilance Programme of the World Health Organization. Ann Allergy Asthma Immunol 2008, 101:67-73.
43. Wolkowitz O.M., Reus U.I. Treatment of depression with antiglucocorticoid drugs. Psychosom Med 1999, 61:698-711.
44. McEwen B.S., Davis P.G., Parsons B., Pfaff D.W. The brain as target for steroid hormone action. Annu Rev Neurosci 1979, 2:65-112.
45. Xu L., Holscher C., Anwyl R., Rowarn M.J. Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress. Proc Natl Acad Sci USA 1998, 95:3204-3208.
46. Brown E.S., Woolston D.J., Frol A.B. Amygdala volume in patients receiving chronic corticosteroid therapy. Biol Psychiatry 2008, 63:705-709.
47. Hall E.D. Glucocorticoid effects on central nervous excitability and synaptic transmission. Int Rev Neurobiol 1982, 23:165-195.
48. Majewska M.D. Steroids and brain activity: essential diaglogue between body and mind. Biochem Pharmacol 1987, 36:3781-3788.
49. Magarinos A.M., Verdugo J.M.G., McEwen B.S. Chronic stress alters synpatic terminal structure in hippocampus. Proc Natl Acad Sci U S A 1997, 94:14002-14008.
50. Lucassen P.J., Muller M.B., Holsboer F., Bauer J., Holtrop A., Wouda J., et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 2001, 158:453-468.
51. Wieck A. Oestradiol and psychosis: clinical findings and biological mechanisms. Curr Top Behav Neurosci 2011, 8:173-187.
52. Lewis A., Fleminger J.J. The psychiatric risk from corticotrophin and cortisone. Lancet 1954, 266(6808):383-386.
53. Wada K., Yamada N., Suzuki H., Lee Y., Kuroda S. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 2000, 61(4):261-267.
54. Malladi A.S., Gratton S.B., Stone D., Scalapino K.J., Charles J.F. Recurrent adverse psychiatric effects following intra-articular corticosteroid injection. J Clin Rheumatol 2011, 17(5):284-285.
55. Frey B.M., Frey F.J. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 1990, 19(2):126-146.
56. Finkenbine R.D., Frye M.D. Case of psychosis due to prednisone-clarithromycin interaction. Gen Hosp Psychiatry 1998, 20(5):325-326.
57. Abouesh A., Stone C., Hobbs W.R. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J Clin Psychopharmacol 2002, 22(1):71-81.
58. Nishimura K., Harigai M., Omori M., Sato E., Hara M. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 2008, 33(3):395-403.
59. Ularntinon S., Tzuang D., Dahl G., Shaw R.J. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 2010, 125(5):e1241-e1245.
60. Manenschijn L., van den Akker E.L., Lamberts S.W., van Rossum E.F. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci 2009, 1179:179-198.
61. Kamdem L.K., Hamilton L., Cheng C., et al. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenet Genomics 2008, 18(6):507-514.
62. Dovio A., Micossi I., Bianco E., Angeli A. Determinants of glucocorticoid action in the bone microenvironment. J Endocrinol Invest 2008, 31(7 Suppl):7-15.
63. Lagomasino I.T., Stern T.A. Steroid psychosis: the neuropsychiatric complications of glucocorticoid use. Med Psychiatry 2001, 4:35-43.
64. Brown E.S. Effects of glucocorticoids on mood, memory, and the hippocampus. Ann NY Acad Sci 2009, 1179:41-55.
65. Falk W.E., Mahnke M.W., Poskanzer D.C. Lithium prophylaxis of corticotropin-induced psychosis. JAMA 1979, 241:1011-1012.
66. Brown E.S., Stuard G., Liggin J.D.M., et al. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biol Psychiatry 2005, 57:543-548.
67. Brown E.S., Frol A., Khan D.A., Larkin G.L., Bret M.E. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur Psychiatry 2007, 22:448-452.
68. Brown E.S., Frol A., Bobadilla L., Nejtek V.A., Perantie D.C., Dhillon H. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics 2003, 44:204-208.
69. Brown E.S., Vazquez M., Nakamura A. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol Psychiatry 2008, (64):727-729.
70. Reus V.I., Wolkowitz O.M. Behavioral side effects of corticosteroid therapy. Psychiatr Ann 1993, 23:703-708.
71. Hall R.C.W., Popkin M.K., Kirkpatrick B. Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis 1978, 166:738-742.
72. Malinow K., Dorsch C. Tricyclic precipitation of steroid psychosis. Psychiatr Med 1984, 2:351-354.
73. Abbas A., Styra S. Valproate prophylaxis against steroid incued psychosis [letter]. Can J Psychiatry 1994, 39:188-189.
74. Preda A., Fazeli A., McKay B.G., Bowers M.B., Mazure C.M. Lamotrigine as prophylaxis against steroid-induced mania [letter]. J Clin Psychiatry 1999, 60:708-709.
75. Terao T., Yoshimura R., Shiratsuchi T., Abe K. Effects of lithium on steroid-induced depression. Biol Psychiatry 1997, 41:1225-1226.
76. Blazer D.G., Petrie W.M., Wilson W.P. Affective psychoses following renal transplant. Dis Nerv Syst 1976, 128:1467-1473.
77. Davis J.M., Leach A., Merk B.S., Janicak P.G. Treatment of steroid psychoses. Psychiatr Ann 1992, 22:487-491.
78. Goldman L.S., Goveas J. Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics 2002, 43:495-497.
79. Brown E.S., Chamberlain W., Dhanani N., Paranjpe P., Carmody T.J., Sargeant M. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affect Disord 2004, 83:277-281.
80. Lupien S.J., McEwen B.S. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev 1997, 24:1-27.
81. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995, 9:89-98.
82. Desai S., Khanani S., Shad M.U., Brown E.S. Attenutation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy. J Clin Psychopharmacol 2009, 29:284-287.
83. Wolkowitz O.M., Rappaport M. Long-lasting behavioral reactions following corticosteroid withdrawal. JAMA 1989, 261:1731-1732.
84. Margolin L., Cope D.K., Bakst-Sisser R., Greenspan J. The steroid withdrawal syndrome: a review of the implications, etiology, and treatments. J Pain Symptom Manage 2007, 33:224-228.
85. Freyberg R.H., Traeger C.H., Patterson M., Squires W., Adams C.H., Stevenson C. Problems of prolonged cortisone treatment for rheumatoid arthritis. JAMA 1951, 68:1538-1543.
86. Dixon R.B., Christy N.P. On the various forms of corticosteroid withdrawal syndrome. Am J Med 1980, 68:224-230.
87. Richter B., Neises G., Clar C. Glucocorticoid withdrawal schemes in chronic medical disorders: A systematic review. Endocrinol Metab Clin N Am 2002, 31:751-778.
88. Cordess C., Folstein M., Drachman D. Psychiatric effects of alternate day steroid therapy. Br J Psychiatry 1981, 138:504-506.
89. Swinburn C., Wakefield J., Newman S., Jones P. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br J Clin Pharmacol 1988, 26:709-713.
90. Gift A., Wood R., Cahill C. Depression, somatization, and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud 1989, 26:281-286.